Letter to Editor on 'A randomized, controlled, blinded, parallel-group, clinical trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India'
Guardado en:
Autores principales: | , , |
---|---|
Formato: | Libro |
Publicado: |
Elsevier,
2022-09-01T00:00:00Z.
|
Materias: | |
Acceso en línea: | Connect to this object online. |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Notas: | 0965-2299 10.1016/j.ctim.2022.102838 |
---|